HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Maria Vittoria Carbone Selected Research
Maria Vittoria Carbone Research Topics
Disease
7
Neoplasms (Cancer)
01/2023 - 03/2007
6
Ovarian Neoplasms (Ovarian Cancer)
01/2023 - 02/2015
4
Endometrial Neoplasms (Endometrial Cancer)
01/2023 - 10/2018
3
Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2023 - 10/2018
3
Ovarian Epithelial Carcinoma
01/2022 - 02/2015
1
Adenocarcinoma
02/2023
1
Adenosquamous Carcinoma
02/2023
1
Microsatellite Instability
12/2022
1
Carcinogenesis
12/2021
1
Carcinoma (Carcinomatosis)
03/2021
1
Hypoxia (Hypoxemia)
03/2007
Drug/Important Bio-Agent (IBA)
5
Platinum
IBA
01/2023 - 02/2015
2
Poly(ADP-ribose) Polymerase Inhibitors
IBA
01/2023 - 03/2021
2
pembrolizumab
IBA
01/2023 - 12/2022
2
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
03/2022 - 03/2021
1
tisotumab vedotin
IBA
01/2023
1
Bevacizumab (Avastin)
FDA Link
01/2023
1
Thromboplastin (Tissue Factor)
IBA
01/2023
1
lenvatinib
IBA
12/2022
1
dostarlimab
IBA
12/2022
1
Ribose (D-Ribose)
IBA
03/2022
1
PM 01183
IBA
01/2022
1
Antineoplastic Agents (Antineoplastics)
IBA
01/2022
1
1,2,3,4-tetrahydroisoquinoline
IBA
01/2022
1
RNA Polymerase II (RNA Polymerase B)
IBA
01/2022
1
Poly Adenosine Diphosphate Ribose
IBA
03/2021
1
Immune Checkpoint Inhibitors
IBA
03/2021
1
Indocyanine Green (Cardio-Green)
FDA Link
Generic
03/2021
1
LPS 9
IBA
10/2018
1
Etoposide (VP 16)
FDA Link
Generic
03/2007
Therapy/Procedure
5
Therapeutics
01/2023 - 03/2021
4
Drug Therapy (Chemotherapy)
01/2023 - 03/2021
2
Hysterectomy
02/2023 - 03/2021
2
Immunotherapy
12/2022 - 03/2021
2
Minimally Invasive Surgical Procedures
03/2021 - 10/2018
2
Lymph Node Excision (Lymph Node Dissection)
03/2021 - 10/2018
1
Cytoreduction Surgical Procedures
03/2021
1
Radiotherapy
03/2021